Integra Lifesciences Holdings Corp

IART's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

IART Growth rates comparisons

Integra Lifesciences Holdings's sales fell by -1.85 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1779

Medical Equipment & Supplies industry recorded growth of revenues by 5.31 %

Integra Lifesciences Holdings's net income grew by 16.66 % in IV. Quarter 2022 year on year, above company average,

• More on IART's Growth

IART's Valuation comparisons

Integra Lifesciences Holdings
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Integra Lifesciences Holdings PEG ratio is at 2.55 Integra Lifesciences Holdings realized cash outflow of $ -0.68per share in trailing twelve-month period.

Company

25.27

PE TTM

Industry

45.92

PE TTM

Company's Price to Sales ratio is at 2.95.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.56.

• More on IART's Valuation

Total Debt (Millions $)	1,339
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	6.34
Tangible Book Value (Per Share $)	-4.32

IART's Valuation comparisons

Company

25.27

PE TTM

Industry

45.92

PE TTM

Company's Price to Sales ratio is at 2.95.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.56.

Integra Lifesciences Holdings Price to Book Ratio is at 2.55 lower than Indusry Avg. of 486.19. and higher than S&P 500 Avg. of -0.01

• More on IART's Valuation

• Market Capitalization (Millions $)	4,593
• Shares Outstanding (Millions)	84
• Employees	-
• Revenues (TTM) (Millions $)	1,558
• Net Income (TTM) (Millions $)	181
• Cash Flow (TTM) (Millions $)	-57
• Capital Exp. (TTM) (Millions $)	-42
• Total Debt (Millions $)	1,339
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	6.34
• Tangible Book Value (Per Share $)	-4.32

• Market Capitalization (Millions $)	4,593
• Shares Outstanding (Millions)	84
• Employees	-
• Revenues (TTM) (Millions $)	1,558
• Net Income (TTM) (Millions $)	181
• Cash Flow (TTM) (Millions $)	-57
• Capital Exp. (TTM) (Millions $)	-42

IART's Profitability Comparisons
Integra Lifesciences Holdings achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 17.04 % from 16.89 % in III. Quarter. Integra Lifesciences Holdings net profit margin of 13.3 % is currently ranking no. 16 in Medical Equipment & Supplies industry, ranking no. 87 in Healthcare sector and number 1033 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	3.62
• Total Debt to Equity (MRQ)	0.74
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.41
• Inventory Turnover Ratio (TTM)	1.83

IART's Profitability Comparisons

Integra Lifesciences Holdings achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 17.04 % from 16.89 % in III. Quarter.

Integra Lifesciences Holdings net profit margin of 13.3 % is currently ranking no. 16 in Medical Equipment & Supplies industry, ranking no. 87 in Healthcare sector and number 1033 in S&P 500.

• More on IART's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar MIMO's Profile Stock Price MIMO's Financials Business Description Fundamentals Charts & Quotes MIMO's News Suppliers MIMO's Competitors Customers & Markets Economic Indicators MIMO's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071